Mammogen Information

Mammogen is a predictive health company developing RNA-powered molecular diagnostics to enable earlier disease detection in women’s health. Our lead product candidate, genTRU-breast, is a blood-based assay designed to provide clinically actionable real-time biologic signal for breast cancer detection, particularly in women with dense breast tissue. Our platform is built on scalable RNA biomarker discovery and computational interpretation, with a pipeline designed to expand into additional women’s health applications over time. Our mission is to preserve quality-of-life through earlier disease detection. And our vision is to become the most trusted brand in women’s health.